LeukoSite, Inc.
🏢 View company profile →6Patents
0Active
6Granted
28Portfolio score
Filing activity: May 16, 1995 → Jan 15, 1999
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6083903A | Boronic ester and acid compounds, synthesis and uses | Human Necessities | 182 | Expired |
| US6245332A | Modulation of systemic memory T cell trafficking | Human Necessities | 36 | Expired |
| US6107073A | Kinase capable of site-specific phosphorylation of I.kappa.B.alpha. | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6037324A | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor | Chemistry; Metallurgy | 21 | Expired |
| US6054579A | Synthesis of substituted lactams | Chemistry; Metallurgy | 7 | Expired |
| US6025384A | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.